Navigation Links
Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
Date:7/25/2012

SAN DIEGO, July 25, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2012 financial results after the Nasdaq market closes on Tuesday, July 31, 2012.  Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Tuesday afternoon, July 31, 2012 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Participants can access the live conference call by dialing 800-862-9098 (US) or 785-424-1051 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600.  A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 800-695-0671 (US) or 402-220-1397 (International) using the conference ID: NBIX. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine-related diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
2. Neurocrine Biosciences Reports First Quarter 2012 Results
3. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
4. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
5. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
6. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
7. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... -- Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe and ... painful intercourse and other painful pelvic pain conditions such as pelvic floor ... ... ... -based start-up company, VuVatech LLC, fills a void in the women,s ...
(Date:7/10/2017)... , July 10, 2017  US medical equipment ... in 2021, according to Medical Equipment & ... by Freedonia Focus Reports. Continued increases in demand for ... aging of the population and supported by gains in ... equipment and supplies. New product introductions will also drive ...
(Date:7/10/2017)... , July 10, 2017  BDI Group subsidiary ... patient support services organization serving specialty pharmacies, home ... launch of four significant, value-added member programs designed ... better manage reimbursement and improve access and affordability ... therapies. ...
Breaking Medicine Technology:
(Date:7/26/2017)... Royal Oak, Michigan (PRWEB) , ... July 26, 2017 , ... ... the newly appointed Medical Director for the treatment program located in Royal Oak, Michigan. ... a group of investors who are focused on providing the highest standards in the ...
(Date:7/26/2017)... ... July 26, 2017 , ... BioPlus ... released an updated version of the HCV Treatment Path app (version 4.4.0) to ... C virus (HCV) infection. All of the latest HCV medications are included in ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... sales department joining as Regional Account Manager for the Northeast and Florida regions. ... the liquidation of their obsolete medical assets. , Jennifer joins Centurion with a ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... Spring Arbor University recently co-authored and published an article in the medical science ... Brachial Plexus Palsy. Both the article and the research that helped produce it, ...
(Date:7/25/2017)... Texas (PRWEB) , ... July 25, 2017 , ... ... Gold Winner for its Product Innovation in the prestigious CEO World Awards®. The ... organizational performance, new products and services, CEO case studies, corporate social responsibility, and ...
Breaking Medicine News(10 mins):